Latest news
{{'2026-06-11T15:30:50Z' | dateFormatFilter}}
Novo Nordisk A/S: IT Security incident at Novo Nordisk
{{'2026-06-11T15:03:13Z' | dateFormatFilter}}
Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK
{{'2026-06-07T21:31:24Z' | dateFormatFilter}}
Novo Nordisk’s CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
